Authors:
Milde-Langosch, K
Riethdorf, S
Kraus-Poppinghaus, A
Riethdorf, L
Loning, T
Citation: K. Milde-langosch et al., Expression of cyclin-dependent kinase inhibitors p16(MTS1), p21(WAF1), andp27(KIP1) in HPV-positive and HPV-negative cervical adenocarcinomas, VIRCHOWS AR, 439(1), 2001, pp. 55-61
Authors:
Milde-Langosch, K
Bamberger, AM
Goemann, C
Rossing, E
Rieck, G
Kelp, B
Loning, T
Citation: K. Milde-langosch et al., Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters, J CANC RES, 127(9), 2001, pp. 537-544
Authors:
Bamberger, AM
Milde-Langosch, K
Rossing, E
Goemann, C
Loning, T
Citation: Am. Bamberger et al., Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators, J CANC RES, 127(9), 2001, pp. 545-550
Authors:
Milde-Langosch, K
Bamberger, AM
Rieck, G
Kelp, B
Loning, T
Citation: K. Milde-langosch et al., Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype, BREAST CANC, 67(1), 2001, pp. 61-70
Authors:
Bamberger, AM
Milde-Langosch, K
Loning, T
Bamberger, CM
Citation: Am. Bamberger et al., The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium, J CLIN END, 86(10), 2001, pp. 5071-5074
Authors:
Milde-Langosch, K
Goemann, C
Methner, C
Rieck, G
Bamberger, AM
Loning, T
Citation: K. Milde-langosch et al., Expression of Rb2/p130 in breast and endometrial cancer: correlations withhormone receptor status, BR J CANC, 85(4), 2001, pp. 546-551
Authors:
Riethdorf, S
Riethdorf, L
Milde-Langosch, K
Park, TW
Loning, T
Citation: S. Riethdorf et al., Differences in HPV 16- and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri, VIRCHOWS AR, 437(5), 2000, pp. 491-500
Citation: K. Milde-langosch et al., Association of human papillomavirus infection with carcinoma of the cervixuteri and its precursor lesions: theoretical and practical implications, VIRCHOWS AR, 437(3), 2000, pp. 227-233
Authors:
Bamberger, AM
Milde-Langosch, K
Schulte, HM
Loning, T
Citation: Am. Bamberger et al., Progesterone receptor isoforms, PR-B and PR-A in breast cancer: Correlations with clinicopathologic tumor parameters and expression of AP-1 factors, HORMONE RES, 54(1), 2000, pp. 32-37
Authors:
Milde-Langosch, K
Bamberger, AM
Methner, C
Rieck, G
Loning, T
Citation: K. Milde-langosch et al., Expression of cell cycle-regulatory proteins Rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: Correlations with expression of activating protein-1 family members, INT J CANC, 87(4), 2000, pp. 468-472
Authors:
Bamberger, AM
Riethdorf, L
Milde-Langosch, K
Bamberger, CM
Thuneke, I
Erdmann, I
Schulte, HM
Loning, T
Citation: Am. Bamberger et al., Strongly reduced expression of the cell cycle inhibitor p27 in endometrialneoplasia, VIRCHOWS AR, 434(5), 1999, pp. 423-428
Citation: K. Milde-langosch et al., Natural course of human papillomavirus (HPV) infection. Effectiveness of HPV analysis in cervical swabs, PATHOLOGE, 20(1), 1999, pp. 15-24
Authors:
Bamberger, AM
Methner, C
Lisboa, BW
Stadtler, C
Schulte, HM
Loning, T
Milde-Langosch, K
Citation: Am. Bamberger et al., Expression pattern of the AP-1 family in breast cancer: Association of fosB expression with a well-differentiated, receptor-positive tumor phenotype, INT J CANC, 84(5), 1999, pp. 533-538